nobiletin has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apaijit, K; Bunbupha, S; Maneesai, P; Pakdeechote, P; Prasarttong, P | 1 |
| Ho, CT; Li, S; Lin, CC; Pan, MH; Wang, P; Wen, X; Yang, G; Yang, Y; Yuan, L; Zhao, H | 1 |
2 other study(ies) available for nobiletin and Vascular Diseases
| Article | Year |
|---|---|
Nobiletin ameliorates high-fat diet-induced vascular and renal changes by reducing inflammation with modulating AdipoR1 and TGF-β1 expression in rats.
Topics: Animals; Antioxidants; Diet, High-Fat; Flavones; Gene Expression Regulation; Inflammation; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Transforming Growth Factor beta1; Vascular Diseases | 2020 |
Nobiletin Prevents Trimethylamine Oxide-Induced Vascular Inflammation via Inhibition of the NF-κB/MAPK Pathways.
Topics: Animals; Aorta; Female; Flavones; Human Umbilical Vein Endothelial Cells; Humans; Liver; Male; Methylamines; Mitogen-Activated Protein Kinase Kinases; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Vascular Diseases | 2019 |